Active	Status	Sponsor type	Region	Phase	Filter
7 Active 24 Inactive 31 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Katz, David
NCT05436652 / 2022-000299-20: A Trial of Prednisolone in Combination With SPI-62 or Placebo in Subjects With Polymyalgia Rheumatica (PMR)	Recruiting	2	72	Europe	SPI-62, SPI-62 matched placebo, Prednisolone 10mg, Additional prednisolone, Additional prednisolone matched placebo	Sparrow Pharmaceuticals	Polymyalgia Rheumatica	04/25	07/25
NCT05409027: A Study to Assess 11 Beta-hydroxysteroid Dehydrogenase Type 1 Inhibition in Adipose Tissue by SPI-62	Completed	1	12	US	SPI-62, HSD-1 inhibitor, Cortisone-d8, Glucocorticoid and anti-inflammatory agent	Sparrow Pharmaceuticals	Type 2 Diabetes Mellitus in Obese, Obesity, Type2Diabetes	03/22	02/24
NCT06281236: A Trial of Prednisolone in Combination With SPI-62 in Participants With Polymyalgia Rheumatica (PMR)	Suspended	1	24	Europe	Prednisolone, SPI-62	Sparrow Pharmaceuticals	Polymyalgia Rheumatica	04/25	04/25
Njike, Valentine
NCT05628597: Effects of Fos Biomedical Device on Diabetes Risk Factors and Sleep Quality in Adults at Risk for Type 2 Diabetes	Completed	N/A	34	US	Fos Biomedical patch product, Fos Biomedical patch product:placebo	Griffin Hospital, Fos Biomedical	Pre Diabetes	11/22	12/22
Lenehan, Peter F
No trials found